Trial · NCT00567502
Results by group149
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 149
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | XAGRID Only | Myocardial infarction | 1.0 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | XAGRID+Other (Cytoreductives) | Myocardial infarction | 0.0 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | Other (Cytoreductives) | Myocardial infarction | 1.5 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | XAGRID Only | Angina | 0.7 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | XAGRID+Other (Cytoreductives) | Angina | 0.0 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | Other (Cytoreductives) | Angina | 0.7 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | XAGRID Only | Congestive heart failure | 1.2 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | XAGRID+Other (Cytoreductives) | Congestive heart failure | 1.4 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | Other (Cytoreductives) | Congestive heart failure | 1.2 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | XAGRID Only | Cardiomyopathy | 0.5 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | XAGRID+Other (Cytoreductives) | Cardiomyopathy | 0.0 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | Other (Cytoreductives) | Cardiomyopathy | 0.3 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | XAGRID Only | Other cardiovascular symptoms | 5.8 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | XAGRID+Other (Cytoreductives) | Other cardiovascular symptoms | 8.5 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | Other (Cytoreductives) | Other cardiovascular symptoms | 3.2 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | XAGRID Only | Stroke | 1.4 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | XAGRID+Other (Cytoreductives) | Stroke | 1.4 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | Other (Cytoreductives) | Stroke | 1.8 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | XAGRID Only | Transient ischemic attack | 1.1 | percentage of participants | |
| Percentage of Participants With At Least One Pre-Defined Event (PDE), Deaths, Pregnancies | XAGRID+Other (Cytoreductives) | Transient ischemic attack | 0.7 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00567502/results